Archive for January, 2013

Recent Rosacea Blog Posts

I have been contacted by a medical marketing company who is looking for female rosacea sufferers aged 30-45 who are available in London and Birmingham in early February. As I understand it the marketing research will relate to feedback on possible future marketing materials. If anyone does go it would be of course interesting to […]

Continue Reading

A patent application has surfaced that shows Galderma claiming an invention that is a diagnostic test for rosacea. A patent application does not guarantee that any particular invention or discovery is valid, just that a company wants to claim the rights to the intellectual property it contains. Indeed some patents will be filed purely to […]

Continue Reading

Rosacea News in 2012

Rosacea News in 2012

Written by on January 12, 2013 in site admin with 4 Comments

What web site visitors don’t typically get any idea about is what is popular on the site they are visiting. Here are some stats from 2012 to give you an idea of what rosacea sufferers most commonly visit on rosacea-support.org. Total Visits The site was viewed about 1.3 million times. This actually down from about […]

Continue Reading

Treating Chalazia with Injected Tetracycline

An upcoming trial will see if injecting Tetracycline into a Chalazion will result in the rapidly clearing of the lesion. 30 patients will a Chalazion will be injected with 0.05mL of 2% tetracycline solution and examined after 4 weeks. A further 30 patients will receive no treatment and be compared to the first group after […]

Continue Reading

New & Emerging Rosacea Treatments Update

A recently published article in Skin Therapy Letter highlights quite a lot of what is interesting in the world of rosacea research. There sure is a lot going in the world of Rosacea! Much of what you will find highlighted will be well known to Rosacea News readers. In fact the list seems so familiar […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.